Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Direct Meds vs Nolu

Direct Meds
Graded #34

Higher grade

vs+7.8999999999999915
Nolu
Graded #115

Lower grade

The verdict

Direct Meds takes it — 77.6/100 to 69.7/100.

Direct Meds grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. One of the few programs offering an oral/sublingual route alongside injectable — semaglutide from ~$179 sublingual (~$297 injectable), tirzepatide ~$224/$399, with an intro promo near $147, all-inclusive and no membership.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueDirect Meds +20
85
65
Dose & formulationDirect Meds +8
88
80
Clinical oversightNolu +10
55
65
Labs & monitoringDirect Meds +18
78
60
FulfillmentNolu +5
80
85
Contract termsDirect Meds +15
80
65
Direct Meds · left barNolu · right bar

The numbers

MetricDirect MedsNolu
WeighScore77.6/10069.7/100
GradeC+C
Scorecard rank#34#115
Semaglutide$249/mo sublingual · $297/mo injectable$249/mo injectable, $279/mo oral — billed per 4 weeks
Tirzepatide$299/mo sublingual · $399/mo injectable$339/mo — billed per 4 weeks
CoverageNot publicly listedAll 50 states plus Washington, D.C.
Brand-name accessCompounded onlyCompounded only
Oral / sublingualYesYes
Direct Meds

Graded #34 · C+

FDAWarning letter issued to directmeds.com, Inc. dba DirectMeds in September 2025. See the FDA warning-letter database.

Strengths

  • Rare oral/sublingual option in addition to injectable
  • All-inclusive pricing with no separate membership fee
  • Both molecules — semaglutide and tirzepatide
  • Intro promotional pricing near $147

Where it loses points

  • Compounded only — not FDA-approved
  • Pricing is company-stated, not independently live-verified
  • Newer and somewhat ambiguous (operates across multiple domains)
  • States served are not disclosed
Nolu

Graded #115 · C

Strengths

  • All-in per-order pricing — consultation, medication and shipping in one figure, no separate membership fee
  • Oral semaglutide ($279 per 4 weeks) alongside the injectable, plus a Microdose GLP-1+B12/NAD+ stack ($179 per 4 weeks)
  • LegitScript verified, available in all 50 states plus Washington, D.C.

Where it loses points

  • Billed "per 4 weeks" rather than calendar month — roughly 8% higher annualized than the $249/$339 headline implies
  • No named medical director, prescribers, or compounding pharmacy disclosed anywhere on the site
  • Compounded only — not the FDA-approved brand product (Wegovy/Ozempic), which matters if you're relying on insurance

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 509 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard